Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Tools & Technology › Informatics › Becton Dickinson Wins $6M Contract to Combat Antimicrobial Resistance

Becton Dickinson Wins $6M Contract to Combat Antimicrobial Resistance

Feb 13, 2020
|
staff reporter

NEW YORK – Becton Dickinson announced on Thursday a $6 million contract with Fleming Fund to provide products to combat antimicrobial resistance in Asia and sub-Saharan Africa.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Infectious Disease

  1. FDA Publishes First Batch of SARS-CoV-2 MDx Limit of Detection Comparison Results

    Premium

  2. Vendors Search for New Applications After SARS-CoV-2 Serology Fails to Fulfill Early Hype

    Premium

  3. Roche Nabs CE Mark for SARS-CoV-2 Quantitative Antibody Test

  4. FDA Grants Emergency Use Authorization to Coronavirus Tests From Visby Medical, SNIBE

  5. Qiagen Acquires Remaining Stake in NeuMoDx Molecular for $248M

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.